Qsam Biosciences Stock Beta
QSAMDelisted Stock | USD 4.49 0.05 1.13% |
Qsam Biosciences fundamentals help investors to digest information that contributes to Qsam Biosciences' financial success or failures. It also enables traders to predict the movement of Qsam OTC Stock. The fundamental analysis module provides a way to measure Qsam Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Qsam Biosciences otc stock.
Qsam |
Qsam Biosciences OTC Stock Beta Analysis
Qsam Biosciences' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Qsam Biosciences Beta | 1.81 |
Most of Qsam Biosciences' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Qsam Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Qsam Biosciences has a Beta of 1.808. This is 110.23% higher than that of the Biotechnology sector and 30.07% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Qsam Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qsam Biosciences' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Qsam Biosciences could also be used in its relative valuation, which is a method of valuing Qsam Biosciences by comparing valuation metrics of similar companies.Qsam Biosciences is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Qsam Biosciences will likely underperform.
Qsam Fundamentals
Return On Equity | -33.77 | |||
Return On Asset | -2.38 | |||
Current Valuation | 36.03 M | |||
Shares Outstanding | 4.45 M | |||
Shares Owned By Insiders | 52.36 % | |||
Price To Book | 201.64 X | |||
Price To Sales | 1.71 X | |||
Gross Profit | 916.67 K | |||
EBITDA | (3.94 M) | |||
Net Income | (4.39 M) | |||
Cash And Equivalents | 429.35 K | |||
Cash Per Share | 0.25 X | |||
Total Debt | 7.5 K | |||
Debt To Equity | 2.08 % | |||
Current Ratio | 0.23 X | |||
Book Value Per Share | 0.04 X | |||
Cash Flow From Operations | (2.85 M) | |||
Earnings Per Share | (1.69) X | |||
Beta | 1.81 | |||
Market Capitalization | 73.79 B | |||
Total Asset | 1.71 M | |||
Retained Earnings | (40.16 M) | |||
Working Capital | 672.35 K | |||
Net Asset | 1.71 M |
About Qsam Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Qsam Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qsam Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qsam Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |